Monetta Financial Services’s Biogen BIIB Stock Holding History

Monetta Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,300	Closed	-$940K	–	47
2023 Q2	$940K	Hold	3,300	–	–	0.92%	25
2023 Q1	$917K	Hold	3,300	–	–	0.98%	21
2022 Q4	$914K	Hold	3,300	–	–	1.05%	22
2022 Q3	$881K	Buy	+3,300	New	+$701K	1%	22
2016 Q1	–	Sell	-1,800	Closed	-$551K	–	80
2015 Q4	$551K	Buy	+1,800	New	+$517K	0.32%	73
2015 Q2	–	Sell	-1,500	Closed	-$633K	–	91
2015 Q1	$633K	Buy	+1,500	New	+$591K	0.34%	56
2014 Q4	–	Sell	-8,000	Closed	-$2.65M	–	58
2014 Q3	$2.65M	Hold	8,000	–	–	1.39%	28
2014 Q2	$2.52M	Hold	8,000	–	–	1.32%	29
2014 Q1	$2.45M	Hold	8,000	–	–	1.32%	21
2013 Q4	$2.24M	Hold	8,000	–	–	1.29%	25
2013 Q3	$1.93M	Buy	+8,000	New	+$1.79M	1.49%	23

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Monetta Financial Services's BIIB Position: Q3 2023 in Review

Monetta Financial Services sold out of Biogen (BIIB) in Q3 2023, closing a stake of 3,300 shares — an estimated $940K sold.

Monetta Financial Services first reported a position in BIIB in Q3 2013 and held it in 11 quarters. The position peaked at $2.65M in Q3 2014. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Monetta Financial Services reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Monetta Financial Services sold 3,300 Biogen shares in Q3 2023, an estimated $940K.
Monetta Financial Services first reported a position in Biogen in Q3 2013 and held it in 11 quarters.
Monetta Financial Services's Biogen position peaked at $2.65M in Q3 2014.
966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Monetta Financial Services's 13F filing for Q3 2023, filed 7 Nov 2023.